KKR is looking to raise $12.5 billion for its fourth pan-Asian fund. It is likely to be the largest-ever Asia-focused, US dollar-denominated fundraise, surpassing Hillhouse Capital’s $10.6 billion close last year.
The target was first reported by Bloomberg, which cited fundraising documents. AVCJ confirmed the figure with sources close to the situation. KKR declined to comment on fundraising. KKR has already flagged...
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.
Kurt Bjorklund, a co-managing partner at Permira, explains how a sector-focused investment style is becoming indispensable in Asia’s competitive and disruption-prone markets
Baibu, a Chinese B2B trading and services platform for the textiles and fabrics industry, has raised a $300 million Series D round led by DST Global.
Food delivery start-up Delivery Hero has agreed to acquire Korean peer Woowa Brothers in a deal that values the target at $4 billion and will facilitate exits for several private equity investors.